PhRMA, a lobbying group for pharmaceutical companies, called the proposal “price controls” and said it was “disappointed the administration put the needs of patients aside with these proposals.” There will likely be escalating pushback from the industry against the new proposal intended to curb high drug prices.
from Kaiser Health News https://ift.tt/2z364PZ
October 26, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Keeping The COVID Plague At Bay: How California Is Protecting Older VeteransDr. Vito Imbasciani has been at war with viruses since he was 5. Growing up near the U.S. Military Academy at West Point in New York, he contracted polio in 1952 and couldn’t walk for two months. In medical school in Vermont … Read More
Analysis: We Knew The Coronavirus Was Coming, Yet We Failed 5 Critical TestsThe arrival of COVID-19 has provided a nuclear-level stress test to the American health care system, and our grade isn’t pretty: at least 73,000 dead, 1.2 million infected and 30 million unemployed; nursing homes, prisons and… Read More
‘An Arm And A Leg’: Health Care Takes A Financial Hit In The Midst Of Pandemic Can’t see the audio player? Click here to listen. About This Podcast Health care — and how much it costs — is scary. But you’re not alone with this stuff, and knowledge is power. “An Arm and a Leg” is a podcast a… Read More
Southwest CEO’s Boast About Airplanes’ Low COVID Risk Flies By Key Concerns “Regarding the risks of coronavirus transmission on an airplane, “it’s as safe as an environment as you’re going to find.” – — Southwest Airlines CEO Gary Kelly, earlier this month on CBS’ “Face the Nation” During a … Read More
COVID Survivors’ Blood Plasma Is A Sought-After New CommodityDiana Berrent learned she had tested positive for COVID-19 on a Wednesday in mid-March. Within a day, she had received 30 emails from people urging her to donate blood. Friends and acquaintances, aware of her diagnosis, passe… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment